Peer-reviewed journal articles (257)
  1. 19. Van Campenhout, C., De Mendonça, R., Alexiou, B., De Clercq, S., Racu, M.-L., Royer-Chardon, C., Rusu, S., Van Eycken, M., Artesi, M., Durkin, K., Mardulyn, P., Bours, V., Decaestecker, C., Remmelink, M., Salmon, I., & D'Haene, N. (2021). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Genome Sequencing from Post-Mortem Formalin-Fixed, Paraffin-Embedded Lung Tissues. The Journal of molecular diagnostics, 23(9), 1065-1077. doi:10.1016/j.jmoldx.2021.05.016
  2. 20. Pastushenko, I., Mauri, F., Song, Y., De Cock, F., Meeusen, B., Swedlund, B., Impens, F., Van Haver, D., Opitz, M., Thery, M., Bareche, Y., Lapouge, G., Vermeersch, M., Van Eycke, Y.-R., Balsat, C., Decaestecker, C., Sokolow, Y., Hassid, S., Perez-Bustillo, A., Agreda-Moreno, B., Rios-Buceta, L., Jaen, P., Redondo, P., Sieira-Gil, R., Millan-Cayetano, J. F., Sanmatrtin, O., D'Haene, N., Moers, V., Rozzi, M., Blondeau, J., Lemaire, S., Scozzaro, S., Janssens, V., De Troya, M., Dubois, C., Perez-Morga, D., Salmon, I., Sotiriou, C., Helmbacher, F., & Blanpain, C. (2021). Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis. Nature (London), 589(7842), 448-455. doi:10.1038/s41586-020-03046-1
  3. 21. Lebrun, L., Melendez Asensio, B., Blanchard, O., De Nève, N., Van Campenhout, C., Lelotte, J., Balériaux, D., Riva, M., Brotchi, J., Bruneau, M., De Witte, O., Decaestecker, C., D'Haene, N., & Salmon, I. (2020). Clinical, radiological and molecular characterization of intramedullary astrocytomas. Acta neuropathologica communications, 8(1). doi:10.1186/s40478-020-00962-1
  4. 22. Remmelink, M., De Mendonça, R., D'Haene, N., De Clercq, S., Verocq, C., Lebrun, L., Lavis, P., Racu, M.-L., Trepant, A.-L., Maris, C., Rorive, S., Goffard, J.-C., De Witte, O., Peluso, L., Vincent, J. L., Decaestecker, C., Taccone, F., & Salmon, I. (2020). Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients. Critical care, 24(1), 495. doi:10.1186/s13054-020-03218-5
  5. 23. Godin, L., Balsat, C., Van Eycke, Y.-R., Allard, J., Royer, C., Remmelink, M., Pastushenko, I., D'Haene, N., Blanpain, C., Salmon, I., Rorive, S., & Decaestecker, C. (2020). A Novel Approach for Quantifying Cancer Cells Showing Hybrid Epithelial/Mesenchymal States in Large Series of Tissue Samples: Towards a New Prognostic Marker. Cancers, 12(4), 906. doi:10.3390/cancers12040906
  6. 24. Verocq, C., Decaestecker, C., Rocq, L., De Clercq, S., Verrellen, A., Mekinda Ngono, Z. L., Ocak, S., Compere, C., Stanciu-Pop, C., Salmon, I., Remmelink, M., & D'Haene, N. (2020). The daily practice reality of PD-L1 (CD274) evaluation in non-small cell lung cancer: A retrospective study. Oncology Letters, 19(5), 3400-3410. doi:10.3892/ol.2020.11458
  7. 25. Gevaert, T., Van Eycke, Y.-R., Vanden Broeck, T., Van Poppel, H., Salmon, I., Rorive, S., Muilwijk, T., Claessens, F., De Ridder, D., Joniau, S., & Decaestecker, C. (2020). The potential of tumour microenvironment markers to stratify the risk of recurrence in prostate cancer patients. PloS one, 15(12), e0244663. doi:10.1371/journal.pone.0244663
  8. 26. Van Eycke, Y.-R., Foucart, A., & Decaestecker, C. (2019). Strategies to Reduce the Expert Supervision Required for Deep Learning-Based Segmentation of Histopathological Images. Frontiers in Medicine, 6, 222. doi:10.3389/fmed.2019.00222
  9. 27. Peerboccus, M., Van Eycke, Y.-R., Gyssels, E., Verset, L., Lucchesi, P., Absil, J., Chao, S.-L., Decaestecker, C., Van Laethem, J.-L., Metens, T., & Bali, M. A. (2019). Volumetric-Based Analysis of In-Vivo and Ex-Vivo Quantitative MR Diffusion Parameters in Pancreatic Adenocarcinoma: Correlation with Pathologic Findings. Japanese Journal of Gastroenterology and Hepatology, 1(4), 1-8.
  10. 28. Lebrun, L., Milowich, D., Le Mercier, M., Allard, J., Van Eycke, Y.-R., Roumeguere, T., Decaestecker, C., Salmon, I., & Rorive, S. (2018). UCA1 overexpression is associated with less aggressive subtypes of bladder cancer. Oncology Reports, 40(5), 2497-2506. doi:10.3892/or.2018.6697
  11. 29. D'Haene, N., Koopmansch, C., Van Eycke, Y.-R., Hulet, F., Allard, J., Bouri, S., Rorive, S., Remmelink, M., Decaestecker, C., Maris, C., & Salmon, I. (2018). The Prognostic Value of the Combination of Low VEGFR-1 and High VEGFR-2 Expression in Endothelial Cells of Colorectal Cancer. International journal of molecular sciences, 19(11), 3536. doi:10.3390/ijms19113536
  12. 30. Van Eycke, Y.-R., Balsat, C., Verset, L., Debeir, O., Salmon, I., & Decaestecker, C. (2018). Segmentation of glandular epithelium in colorectal tumours to automatically compartmentalise IHC biomarker quantification: a deep learning approach. Medical image analysis, 49, 35-45. doi:10.1016/j.media.2018.07.004
  13. 31. Gevaert, T., Van Eycke, Y.-R., Vanden Broeck, T., Van Poppel, H., Salmon, I., Rorive, S., Claessens, F., De Ridder, D., Decaestecker, C., & Joniau, S. (2018). Comparing the expression profiles of steroid hormone receptors and stromal cell markers in prostate cancer at different Gleason scores. Scientific reports, 8(1), 14326. doi:10.1038/s41598-018-32711-9
  14. 32. Tosco, L., Laenen, A., Gevaert, T., Salmon, I., Decaestecker, C., Davicioni, E., Buerki, C., Claessens, F., Swinnen, J., Goffin, K., Oyen, R., Everaerts, W., Moris, L., De Meerleer, G., Haustermans, K., Joniau, S., & P.E.A.R.L. (ProstatE cAncer Research Leuven), (2018). Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial. BMC cancer, 18(1), 354. doi:10.1186/s12885-018-4275-z
  15. 33. Roumeguere, T., Legrand, F., El Rassy, E., Idrissi Kaitouni, M., Albisinni, S., Rousseau, A., Vanhaeverbeek, M., Rorive, S., Decaestecker, C., Debeir, O., Zouaoui Boudjeltia, K., & Aoun, F. (2018). A prospective clinical study of the implications of IL-8 in the diagnosis, aggressiveness and prognosis of prostate cancer. Future science OA, 4(2), FSO266. doi:10.4155/fsoa-2017-0084
  16. 34. Fontaine, M., Vogel, I., Van Eycke, Y.-R., Galuppo, A., Ajouaou, Y., Decaestecker, C., Kassiotis, G., Moser, M., & Leo, O. (2018). Regulatory T cells constrain the TCR repertoire of antigen-stimulated conventional CD4 T cells. EMBO journal, 37(3), 398-412. doi:10.15252/embj.201796881
  17. 35. Arcolia, V., Boutry, S., Laurent, S., Saussez, S., Journé, F., Wattier, A., Leteurtre, E., Renaud, F., Gabius, H.-J., Remmelink, M., Decaestecker, C., & Rodriguez, A. (2017). Galectin-1 is a diagnostic marker involved in thyroid cancer progression. International journal of oncology, 51(3), 760-770. doi:10.3892/ijo.2017.4065
  18. 36. Buisseret, L., Desmedt, C., Garaud, S., Fornili, M., Wang, X., Van den Eyden, G., de Wind, A., Duquenne, S., Boisson, A., Naveaux, C., Rothé, F., Rorive, S., Decaestecker, C., Larsimont, D., Piccart-Gebhart, M., Biganzoli, E., Sotiriou, C., & Willard-Gallo, K. (2017). Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer. Modern pathology, 30(9), 1204-1212. doi:10.1038/modpathol.2017.43
  19. 37. Verset, L., Tommelein, J., Decaestecker, C., De Vlieghere, E., Bracke, M., Salmon, I., De Wever, O., & Demetter, P. (2017). ADAM-17/FHL2 Colocalisation Suggests Interaction and Role of These Proteins in Colorectal Cancer. Tumor biology, 39(3), 1010428317695024. doi:10.1177/1010428317695024
  20. 38. Van Eycke, Y.-R., Allard, J., Salmon, I., Debeir, O., & Decaestecker, C. (2017). Image processing in digital pathology: an opportunity to solve inter-batch variability of immunohistochemical staining. Scientific Reports, 7, 42964. doi:10.1038/srep42964
    21. << Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next >>